- Home
- A-Z Publications
- Reviews on Recent Clinical Trials
- Previous Issues
- Volume 13, Issue 2, 2018
Reviews on Recent Clinical Trials - Volume 13, Issue 2, 2018
Volume 13, Issue 2, 2018
-
-
Dyspnea in Cancer Patients: A Well-Known and Neglected Symptom
More LessBackground: Dyspnea is a very common and well-known symptom in patients with advanced cancer, but it is often neglected by physicians. Moreover, despite the high frequency of dyspnea, few controlled studies have been conducted on cancer patients. In most cases, this ‘awareness of breathing with difficulty’ and its severity can only be judged by the patient. Moderate or severe dyspnea is described in 20-80% of pati Read More
-
-
-
The Use of Probiotics in Different Phases of Diverticular Disease
Background & Aims: Diverticular Disease (DD) is a common clinical condition with a dramatic increasing of the prevalence among industrialized countries. Based on the most used classification, DD may be divided into asymptomatic diverticulosis, symptomatic uncomplicated diverticular disease and complicated diverticular disease. Since recent studies pointed out the role of GUT microbiota imbalance in promoting diverti Read More
-
-
-
Basics in Endoscopic Ultrasound Part 2: EUS-guided Sampling and Therapeutic Applications
Background: Endoscopic ultrasound (EUS) has been used in the clinical arena for almost 35 years and it is now well-integrated in everyday hospital practice. Method: We conducted a systematic review of the available English-language articles. Objective: The purpose of this review is to summarize the relevant applications of operative EUS. Results: More than 5000 scientific papers published in the literature have demons Read More
-
-
-
Lupus Nephritis: Current Treatment Paradigm and Unmet Needs
Authors: Steven P. Menez, Basset El Essawy and Mohamed G. AttaBackground: Systemic Lupus Erythematosus (SLE) is an autoimmune disorder characterized by chronic inflammation, which can result in a multitude of systemic or organ-limited manifestations, including the skin, lungs, heart, and kidney. SLE nephritis is present in an average of 38% of patients at the time of diagnosis, and may occur as the initial presentation of disease with progression to End-Stage Renal Disease (ESR Read More
-
-
-
Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine
Authors: Mathieu Di Miceli and Benjamin GronierBackground: Metadoxine is composed of pyroglutamic acid and vitamin B6. Administrations of metadoxine are indicated in cases of acute alcohol intoxication or in chronic alcoholism. Objectives: To reference all available clinical trials investigating the effects of metadoxine on humans. A focus was put on alcohol intoxication and chronic alcoholism, alcohol abstinence and survival rates. Adverse events were also taken into consi Read More
-
-
-
ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children
Authors: Burca Aydin, Canan Akyuz, Ali Varan, Bilgehan Yalcin, Nilgun Kurucu and Tezer KutlukBackground: The outcome of bone and soft tissue sarcomas (BST) after relapse has very poor prognosis with survival rates less than 39%. Unfortunately there are not many treatment options, but promising responses have been reported with ifosfamide, etoposide and carboplatin (ICE). Objective: Therefore, we planned a study for children with recurrent/refractory BST treated with ICE regimen to evaluate their demogra Read More
-
-
-
Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial
Objective: Oxidative stress and Overproduction of pro-inflammatory cytokines are contributed in Rheumatoid Arthritis (RA) pathogenesis. N-acetylcysteine (NAC) is an antioxidant and antiinflammatory agent which demonstrated analgesic effects in some studies. This study is designed to assess the effects of oral NAC as an adjuvant therapy on the clinical outcomes of patients with active RA. Methods: In this randomized cli Read More
-
-
-
Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer
Authors: Matthew Snyder, Sal Bottiglieri and Khaldoun AlmhannaBackground: Colorectal cancer is one of the most common malignancies in the United States, with a large proportion of patients presenting with metastatic disease or developing a recurrence. Systemic chemotherapy is the mainstay of therapy in this setting. There is a clear benefit in the addition of bevacizumab or cetuximab (for rat sarcoma [RAS] wild type tumors) to oxaliplatin- and irinotecan-based regimens which can Read More
-
-
-
Arnica compositum, Hekla lava and Acidum Nitricum Together are Superior to Arnica compositum Alone in the Local Treatment of Symptomatic Calcific Periarthritis of the Shoulder: A Pilot Study
Background: To evaluate the usefulness of Arnica compositum (AC) + Acidum nitricum (AN) + Hekla lava (HL) ointment in Emergency Medicine Department (EMD) as alternative nonpharmacological local treatment of patients with symptomatic calcific periarthritis of the shoulder (CPS) and to compare the effectiveness of this mixture against AC ointment alone. Methods: A series of 41 consecutive patients (20 women, 19 me Read More
-
-
-
Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-glucose Cotransporter-2 Inhibitors - A Case Series
Authors: Purva V. Sharma, Yash B. Jobanputra, Karen Lewin, Stuart Bagatell and Daniel M. LichtsteinBackground: Diabetic ketoacidosis (DKA) is a serious complication of diabetes seen commonly in autoimmune Type 1 diabetes mellitus (DM), however patients with Type 2 diabetes are also at risk. Diabetic ketoacidosis may be precipitated by the catabolic stress of acute illness such as trauma, surgery, or infections. Recent studies have suggested that sodium-glucose cotransporter-2 (SGLT-2) inhibitors precipitate DKA in Read More
-
Volumes & issues
-
Volume 20 (2025)
-
Volume 19 (2024)
-
Volume 18 (2023)
-
Volume 17 (2022)
-
Volume 16 (2021)
-
Volume 15 (2020)
-
Volume 14 (2019)
-
Volume 13 (2018)
-
Volume 12 (2017)
-
Volume 11 (2016)
-
Volume 10 (2015)
-
Volume 9 (2014)
-
Volume 8 (2013)
-
Volume 7 (2012)
-
Volume 6 (2011)
-
Volume 5 (2010)
-
Volume 4 (2009)
-
Volume 3 (2008)
-
Volume 2 (2007)
-
Volume 1 (2006)
Most Read This Month
Article
content/journals/rrct
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
-
COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information
Authors: Davide Mauri, Konstantinos Kamposioras, Lampriani Tsali, Mario Dambrosio, Berardino De Bari, Nadia Hindi, Carl Salembier, Joanna Nixon, Tzachanis Dimitrios, Flippo Alongi, Hassan Hameed, Antonios Valachis, Konstantinos Papadimitriou, Stefanie Corradini, Lazar Popovic, Jindrich Kopecky, Andres Rodriguez, Katarina Antunac, Junlin Yi, Jozsef Lovey, Primoz Strojan, Haytham Saraireh, Ranveig Røtterud, Marzanna Chojnacka, Santa C. Olalla, Natalia Chilingirova, Ramon Andrade De Mello, Giovanna Araujo Amaral, Farsid Arbabi, Radu Vidra, Erjeta Rapushi, Dan Takeuchi, Chirstos Christopoulos, Irina Ivanova, Igor Djan, Branka Petricevic, Francesco Cellini, Iglika Mihaylova, Natalija Dedic Plavetic, Cvetka Grašič Kuhar, Elena Takeuchi, Pantelis Kountourakis, Panagiotis Ntellas, Ioanna Gazouli, Stefania Gkoura, Salih Yuce, Özlem ER, Chait Yasmina, Gireesh Kumaran, Orges Spahiu, Aasim Yusuf, Paulina Gono, Kathi Apostolidis and Maria Tolia
-
-
-
-
Deep Neck Infections: Decisional Algorithm for Patients with Multiple Spaces Involvement
Authors: Filippo Ricciardiello, Salvatore Mazzone, Pasquale Viola, Gianluca Guggino, Giuseppe Longo, Alberto Napolitano, Giuseppe Russo, Giulio Sequino, Flavia Oliva, Pasquale Salomone, Marco Perrella, Giovanni M. Romano, Pietro Cinaglia, Teresa Abate, Maurizio Gargiulo, Davide Pisani and Giuseppe Chiarella
-
- More Less